1. 2249 Comparison of Everolimus (EV) plus somatostatin analog (SSA) administered before or after chemotherapy (CT) or PRRT in advanced G1-G2 Neuroendocrine Tumor (NET) progressed after SSA: analysis of different sequences in single center experience. (September 2015) Authors: Marconcini, R.; Ricci, S.; Antonuzzo, A.; Galli, L.; Vasile, E.; Farnesi, A.; Derosa, L.; Biasco, E.; Falcone, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2311 Evaluation of predictive factors of efficacy of Somatostatin Analogs (SSA) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET): a single centre experience. (September 2015) Authors: Marconcini, R.; Ricci, S.; Galli, L.; Antonuzzo, A.; Vasile, E.; Pancrazi, F.; Farnesi, A.; Derosa, L.; Biasco, E.; Falcone, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis. (February 2017) Authors: De Lisi, D.; Maruzzo, M.; Galli, L.; Biasco, E.; Farnesi, A.; Procopio, G.; Ratta, R.; Buti, S.; Sternberg, C.N.; Cerbone, L.; Di Lorenzo, G.; Pantano, F.; Sterpi, M.; De Giorgi, U.; Berardi, R.; Torinai, M.; Camerini, A.; Massari, F.; Tonini, G.; Santini, D. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗